Summary
This paper investigates the effectiveness of Blue Light Therapy (BLT) as a non-pharmacologic approach to treating symptoms of Post-Traumatic Stress Disorder (PTSD), and improving emotional processing, as measured by the Masked Affect Task (MAT).
Categories
Post-Traumatic Stress Disorder (PTSD): The paper focuses on the use of Blue Light Therapy as a potential treatment for PTSD, investigating its effects on emotional processing and overall symptom severity.
Phototherapy: Blue Light Therapy, a form of phototherapy, is the primary treatment method being investigated in this study for its potential benefits in treating PTSD.
Sleep and insomnia: The paper discusses the relationship between sleep disturbances and PTSD, and hypothesizes that Blue Light Therapy could help improve sleep patterns in individuals with PTSD.
Mood regulation: The paper discusses the potential of Blue Light Therapy to improve mood regulation in individuals with PTSD, as it has been shown to have mood-enhancing effects in other disorders.
Neuroscience and Cognitive Science: The paper explores the neural mechanisms behind the potential benefits of Blue Light Therapy in treating PTSD, including its effects on the amygdala and prefrontal cortex.
Author(s)
D Jecmen
Publication Year
2020
Related Publications
Post-Traumatic Stress Disorder (PTSD)
- Treatment with morning blue light increases left amygdala volume and sleep duration among individuals with posttraumatic stress disorder
- Morning light treatment for traumatic stress: The role of amygdala reactivity study protocol
- Impact of blue light exposition to alertness of shift workers, patients with sleep deprivation, Alzheimer's disease, or post-traumatic stress disorder
- Trastorno de estrés post-traumático y tratamiento con EMDR desde la neuropsicología
- Absence of VGLUT3 expression leads to impaired fear memory in mice
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- Short‐wavelength enrichment of polychromatic light enhances human melatonin suppression potency
Sleep and insomnia
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
- Functional and morphological differences among intrinsically photosensitive retinal ganglion cells
- The impact of light from computer monitors on melatonin levels in college students
Mood regulation
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Nocturnal light exposure impairs affective responses in a wavelength-dependent manner
- The role of the circadian clock in animal models of mood disorders.
- Signalling by melanopsin (OPN4) expressing photosensitive retinal ganglion cells
- Early electronic screen exposure and autistic-like symptoms